Guardian Pharmacy Services (NYSE:GRDN) Rating Increased to Strong-Buy at Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday.

Several other equities research analysts also recently weighed in on GRDN. Truist Financial reaffirmed a “buy” rating and set a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Raymond James Financial set a $28.00 price target on Guardian Pharmacy Services and gave the stock an “outperform” rating in a research report on Wednesday, May 14th.

Guardian Pharmacy Services Price Performance

NYSE GRDN opened at $23.60 on Friday. The stock’s fifty day moving average price is $20.74 and its 200 day moving average price is $21.49. Guardian Pharmacy Services has a 1 year low of $14.16 and a 1 year high of $26.91. The company has a market cap of $1.49 billion and a price-to-earnings ratio of -15.53.

Insider Activity at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director John Ackerman sold 201,303 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $4,058,268.48. Following the sale, the director directly owned 149,794 shares of the company’s stock, valued at approximately $3,019,847.04. This trade represents a 57.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas J. Salentine, Jr. sold 651,454 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $13,133,312.64. Following the sale, the director directly owned 1,939,817 shares in the company, valued at $39,106,710.72. This represents a 25.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,344,912 shares of company stock worth $228,713,426 in the last three months. Company insiders own 63.71% of the company’s stock.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of institutional investors have recently modified their holdings of the business. Envestnet Asset Management Inc. grew its position in shares of Guardian Pharmacy Services by 4.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company’s stock valued at $243,000 after acquiring an additional 564 shares during the period. LPL Financial LLC grew its position in shares of Guardian Pharmacy Services by 4.8% during the 4th quarter. LPL Financial LLC now owns 17,679 shares of the company’s stock valued at $358,000 after acquiring an additional 807 shares during the period. GAMMA Investing LLC acquired a new stake in shares of Guardian Pharmacy Services during the 1st quarter valued at about $170,000. Lazard Asset Management LLC grew its position in shares of Guardian Pharmacy Services by 0.5% during the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company’s stock valued at $3,865,000 after acquiring an additional 860 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey grew its position in shares of Guardian Pharmacy Services by 76.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after acquiring an additional 1,062 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.